Esophagectomy in patients with esophageal squamous cell carcinoma and distant nodal metastasis
Diseases of the Esophagus · 2024
DOI: 10.1093/dote/doae064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2024. Verfasst von Chia Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Esophagectomy, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Lymphatic Metastasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
The role of surgery in oligometastatic esophageal squamous cell carcinoma (ESCC) remains controversial. This study evaluated the oncological outcomes after esophagectomy in patients with ESCC with distant lymph node (LN) metastasis. Patients with ESCC and nodal metastasis treated with chemoradiotherapy or chemotherapy followed by esophagectomy between 2010 and 2020 were included. Overall survival (OS) and recurrence-free survival (RFS) were compared between patients with distant LN metastasis (dLN+) and exclusively regional LN metastasis (dLN–). The cohort comprised 69 dLN+ and 111 dLN– patients. Survival was significantly better in the dLN– group than in the dLN+ group (5-year OS, 51.9% vs. 25.5%, P < 0.001; RFS, 47.2% vs. 18.1%, P < 0.001). Stratified by the yp stage, 49 (44.1%) dLN– and 30 (43.5%) dLN+ patients achieved a pathological complete response (pCR). In the dLN– and dLN+ groups, the OS rates were significantly higher in the pCR group than in the non-pCR group (dLN–: 76.7% vs. 32.4%, P < 0.001; dLN+: 39.6% vs. 14.2%; P = 0.002). The dLN–/pCR group had the best OS, significantly outperforming the dLN−/non-pCR and dLN+/pCR groups. OS did not differ between the dLN−/non-pCR and dLN+/pCR groups. The dLN+/non-pCR group had the worst OS. The RFS analysis paralleled the OS findings. Patients with dLN+ disease had worse outcomes than their dLN– counterparts, irrespective of the pCR status. The survival rates were poor but comparable between the dLN+/pCR and dLN−/non-pCR groups. Adjuvant therapy may be required for dLN+ patients following systemic treatment and surgery, even after achieving pCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Thoracic Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Thoracic Surgery, Department of Surgery, New Taipei City Hospital, New Taipei City, Taiwan.
ORCID-Profile: Chia Liu, Ping-Chung Tsai, Po-Kuei Hsu
Zitieren
APA
Liu, C., Tsai, P. C., Chien, L. I., Huang, C. S., Hsieh, C. C., Hsu, H. S., & Hsu, P. K. (2024). Esophagectomy in patients with esophageal squamous cell carcinoma and distant nodal metastasis. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae064
Vancouver
Liu C, Tsai PC, Chien LI, Huang CS, Hsieh CC, Hsu HS, et al. Esophagectomy in patients with esophageal squamous cell carcinoma and distant nodal metastasis. Diseases of the Esophagus. 2024. doi:10.1093/dote/doae064
BibTeX
@article{Liu2024,
author = {Liu, Chia and Tsai, Ping-Chung and Chien, Ling-I and Huang, Chien-Sheng and Hsieh, Chih-Cheng and Hsu, Han-Shui and Hsu, Po-Kuei},
title = {Esophagectomy in patients with esophageal squamous cell carcinoma and distant nodal metastasis},
journal = {Diseases of the Esophagus},
year = {2024},
doi = {10.1093/dote/doae064}
}
EUVIMED